Immunocore Holdings plc (IMCR) SEC Filings https://www.immunocore.com/investors/financials-filings/annual-reports/rss Immunocore Holdings plc (IMCR) - Annual Reports en-us https://d1io3yog0oux5.cloudfront.net/_b541aae032f58bf8fdbdeabb137fc49f/immunocore/files/theme/images/logo-sm.png Immunocore Holdings plc Logo /investors Equisolve Investor Relations Suite <![CDATA[ARS - Annual Report to Security Holders]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-015125/0001140361-26-015125.pdf Thu, 16 Apr 26 16:07:10 -0400 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-015125/0001140361-26-015125.pdf <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001671927-26-000005/0001671927-26-000005.pdf Wed, 25 Feb 26 07:02:00 -0500 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001671927-26-000005/0001671927-26-000005.pdf <![CDATA[ARS - Annual Report to Security Holders]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-25-012125/0001140361-25-012125.pdf Fri, 04 Apr 25 06:06:42 -0400 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-25-012125/0001140361-25-012125.pdf <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001671927-25-000006/0001671927-25-000006.pdf Wed, 26 Feb 25 07:01:35 -0500 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001671927-25-000006/0001671927-25-000006.pdf <![CDATA[ARS - Annual report to security holders]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-24-019632/0001140361-24-019632.pdf Fri, 12 Apr 24 16:35:07 -0400 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-24-019632/0001140361-24-019632.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-24-009921/0001140361-24-009921.pdf Wed, 28 Feb 24 07:34:57 -0500 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-24-009921/0001140361-24-009921.pdf <![CDATA[20-F - Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-23-009313/0001140361-23-009313.pdf Mon, 12 Jun 23 17:39:32 -0400 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-23-009313/0001140361-23-009313.pdf <![CDATA[20-F - Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-22-007578/0001140361-22-007578.pdf Mon, 12 Jun 23 17:32:33 -0400 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-22-007578/0001140361-22-007578.pdf <![CDATA[20-F - Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-21-009904/0001140361-21-009904.pdf Mon, 12 Jun 23 17:29:30 -0400 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-21-009904/0001140361-21-009904.pdf